Report Detail
Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Growth 2022-2028
- RnM4496304 |
- 06 December, 2022 |
- Global |
- 103 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Nonsteroidal anti-inflammatory drugs (NSAIDs) are medicines that are commonly used for pain relief, stress reduction and high temperature control. They are often used to relieve symptoms of periods of pain, sprains and strains, headaches, cold and flu, arthritis and other long-term pain causes. Non-steroidal medications have sedative and anti-inflammatory effects. Inflammation is caused by the COX-1 and COX-2 enzymes which are inhibited by non-steroidal anti-inflammatory medications (NSAIDs). Some common examples of typical non-steroidal anti-inflammatory medications include aspirin, naproxen, ibuprofen, and paracetamol.
The global market for Oral Nonsteroidal Anti-Inflammatory Drugs is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Oral Nonsteroidal Anti-Inflammatory Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Oral Nonsteroidal Anti-Inflammatory Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Oral Nonsteroidal Anti-Inflammatory Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Oral Nonsteroidal Anti-Inflammatory Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Oral Nonsteroidal Anti-Inflammatory Drugs players cover Bayer AG, Pfizer Inc, Reckitt Benckiser Group PLC, Novartis AG and DAIICHI SANKYO COMPANY, LIMITED, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Oral Nonsteroidal Anti-Inflammatory Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Oral Nonsteroidal Anti-Inflammatory Drugs market, with both quantitative and qualitative data, to help readers understand how the Oral Nonsteroidal Anti-Inflammatory Drugs market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Oral Nonsteroidal Anti-Inflammatory Drugs market and forecasts the market size by Type (Penecillins, Cephalosporins and Tetracyclins), by Application (Sterilization and Bacteriostasis.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Penecillins
Cephalosporins
Tetracyclins
Sulfonamides
Other
Segmentation by application
Sterilization
Bacteriostasis
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Bayer AG
Pfizer Inc
Reckitt Benckiser Group PLC
Novartis AG
DAIICHI SANKYO COMPANY, LIMITED
Zydus Group
Lupin
GSK Plc
Glenmark Pharmaceuticals Inc
Amneal Pharmaceuticals
AstraZeneca
Chapter Introduction
Chapter 1: Scope of Oral Nonsteroidal Anti-Inflammatory Drugs, Research Methodology, etc.
Chapter 2: Executive Summary, global Oral Nonsteroidal Anti-Inflammatory Drugs market size (sales and revenue) and CAGR, Oral Nonsteroidal Anti-Inflammatory Drugs market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Oral Nonsteroidal Anti-Inflammatory Drugs sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Oral Nonsteroidal Anti-Inflammatory Drugs sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Oral Nonsteroidal Anti-Inflammatory Drugs market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Bayer AG, Pfizer Inc, Reckitt Benckiser Group PLC, Novartis AG, DAIICHI SANKYO COMPANY, LIMITED, Zydus Group, Lupin, GSK Plc and Glenmark Pharmaceuticals Inc, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Oral Nonsteroidal Anti-Inflammatory Drugs Annual Sales 2017-2028
- 2.1.2 World Current & Future Analysis for Oral Nonsteroidal Anti-Inflammatory Drugs by Geographic Region, 2017, 2022 & 2028
- 2.1.3 World Current & Future Analysis for Oral Nonsteroidal Anti-Inflammatory Drugs by Country/Region, 2017, 2022 & 2028
- 2.2 Oral Nonsteroidal Anti-Inflammatory Drugs Segment by Type
- 2.2.1 Penecillins
- 2.2.2 Cephalosporins
- 2.2.3 Tetracyclins
- 2.2.4 Sulfonamides
- 2.2.5 Other
- 2.3 Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Type
- 2.3.1 Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales Market Share by Type (2017-2022)
- 2.3.2 Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue and Market Share by Type (2017-2022)
- 2.3.3 Global Oral Nonsteroidal Anti-Inflammatory Drugs Sale Price by Type (2017-2022)
- 2.4 Oral Nonsteroidal Anti-Inflammatory Drugs Segment by Application
- 2.4.1 Sterilization
- 2.4.2 Bacteriostasis
- 2.5 Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Application
- 2.5.1 Global Oral Nonsteroidal Anti-Inflammatory Drugs Sale Market Share by Application (2017-2022)
- 2.5.2 Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue and Market Share by Application (2017-2022)
- 2.5.3 Global Oral Nonsteroidal Anti-Inflammatory Drugs Sale Price by Application (2017-2022)
3 Global Oral Nonsteroidal Anti-Inflammatory Drugs by Company
- 3.1 Global Oral Nonsteroidal Anti-Inflammatory Drugs Breakdown Data by Company
- 3.1.1 Global Oral Nonsteroidal Anti-Inflammatory Drugs Annual Sales by Company (2020-2022)
- 3.1.2 Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales Market Share by Company (2020-2022)
- 3.2 Global Oral Nonsteroidal Anti-Inflammatory Drugs Annual Revenue by Company (2020-2022)
- 3.2.1 Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Company (2020-2022)
- 3.2.2 Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Market Share by Company (2020-2022)
- 3.3 Global Oral Nonsteroidal Anti-Inflammatory Drugs Sale Price by Company
- 3.4 Key Manufacturers Oral Nonsteroidal Anti-Inflammatory Drugs Producing Area Distribution, Sales Area, Product Type
- 3.4.1 Key Manufacturers Oral Nonsteroidal Anti-Inflammatory Drugs Product Location Distribution
- 3.4.2 Players Oral Nonsteroidal Anti-Inflammatory Drugs Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Oral Nonsteroidal Anti-Inflammatory Drugs by Geographic Region
- 4.1 World Historic Oral Nonsteroidal Anti-Inflammatory Drugs Market Size by Geographic Region (2017-2022)
- 4.1.1 Global Oral Nonsteroidal Anti-Inflammatory Drugs Annual Sales by Geographic Region (2017-2022)
- 4.1.2 Global Oral Nonsteroidal Anti-Inflammatory Drugs Annual Revenue by Geographic Region
- 4.2 World Historic Oral Nonsteroidal Anti-Inflammatory Drugs Market Size by Country/Region (2017-2022)
- 4.2.1 Global Oral Nonsteroidal Anti-Inflammatory Drugs Annual Sales by Country/Region (2017-2022)
- 4.2.2 Global Oral Nonsteroidal Anti-Inflammatory Drugs Annual Revenue by Country/Region
- 4.3 Americas Oral Nonsteroidal Anti-Inflammatory Drugs Sales Growth
- 4.4 APAC Oral Nonsteroidal Anti-Inflammatory Drugs Sales Growth
- 4.5 Europe Oral Nonsteroidal Anti-Inflammatory Drugs Sales Growth
- 4.6 Middle East & Africa Oral Nonsteroidal Anti-Inflammatory Drugs Sales Growth
5 Americas
- 5.1 Americas Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Country
- 5.1.1 Americas Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Country (2017-2022)
- 5.1.2 Americas Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Country (2017-2022)
- 5.2 Americas Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Type
- 5.3 Americas Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Region
- 6.1.1 APAC Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Region (2017-2022)
- 6.1.2 APAC Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Region (2017-2022)
- 6.2 APAC Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Type
- 6.3 APAC Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Application
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 China Taiwan
7 Europe
- 7.1 Europe Oral Nonsteroidal Anti-Inflammatory Drugs by Country
- 7.1.1 Europe Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Country (2017-2022)
- 7.1.2 Europe Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Country (2017-2022)
- 7.2 Europe Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Type
- 7.3 Europe Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Oral Nonsteroidal Anti-Inflammatory Drugs by Country
- 8.1.1 Middle East & Africa Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Country (2017-2022)
- 8.1.2 Middle East & Africa Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Country (2017-2022)
- 8.2 Middle East & Africa Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Type
- 8.3 Middle East & Africa Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
- 10.1 Raw Material and Suppliers
- 10.2 Manufacturing Cost Structure Analysis of Oral Nonsteroidal Anti-Inflammatory Drugs
- 10.3 Manufacturing Process Analysis of Oral Nonsteroidal Anti-Inflammatory Drugs
- 10.4 Industry Chain Structure of Oral Nonsteroidal Anti-Inflammatory Drugs
11 Marketing, Distributors and Customer
- 11.1 Sales Channel
- 11.1.1 Direct Channels
- 11.1.2 Indirect Channels
- 11.2 Oral Nonsteroidal Anti-Inflammatory Drugs Distributors
- 11.3 Oral Nonsteroidal Anti-Inflammatory Drugs Customer
12 World Forecast Review for Oral Nonsteroidal Anti-Inflammatory Drugs by Geographic Region
- 12.1 Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Size Forecast by Region
- 12.1.1 Global Oral Nonsteroidal Anti-Inflammatory Drugs Forecast by Region (2023-2028)
- 12.1.2 Global Oral Nonsteroidal Anti-Inflammatory Drugs Annual Revenue Forecast by Region (2023-2028)
- 12.2 Americas Forecast by Country
- 12.3 APAC Forecast by Region
- 12.4 Europe Forecast by Country
- 12.5 Middle East & Africa Forecast by Country
- 12.6 Global Oral Nonsteroidal Anti-Inflammatory Drugs Forecast by Type
- 12.7 Global Oral Nonsteroidal Anti-Inflammatory Drugs Forecast by Application
13 Key Players Analysis
- 13.1 Bayer AG
- 13.1.1 Bayer AG Company Information
- 13.1.2 Bayer AG Oral Nonsteroidal Anti-Inflammatory Drugs Product Offered
- 13.1.3 Bayer AG Oral Nonsteroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.1.4 Bayer AG Main Business Overview
- 13.1.5 Bayer AG Latest Developments
- 13.2 Pfizer Inc
- 13.2.1 Pfizer Inc Company Information
- 13.2.2 Pfizer Inc Oral Nonsteroidal Anti-Inflammatory Drugs Product Offered
- 13.2.3 Pfizer Inc Oral Nonsteroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.2.4 Pfizer Inc Main Business Overview
- 13.2.5 Pfizer Inc Latest Developments
- 13.3 Reckitt Benckiser Group PLC
- 13.3.1 Reckitt Benckiser Group PLC Company Information
- 13.3.2 Reckitt Benckiser Group PLC Oral Nonsteroidal Anti-Inflammatory Drugs Product Offered
- 13.3.3 Reckitt Benckiser Group PLC Oral Nonsteroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.3.4 Reckitt Benckiser Group PLC Main Business Overview
- 13.3.5 Reckitt Benckiser Group PLC Latest Developments
- 13.4 Novartis AG
- 13.4.1 Novartis AG Company Information
- 13.4.2 Novartis AG Oral Nonsteroidal Anti-Inflammatory Drugs Product Offered
- 13.4.3 Novartis AG Oral Nonsteroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.4.4 Novartis AG Main Business Overview
- 13.4.5 Novartis AG Latest Developments
- 13.5 DAIICHI SANKYO COMPANY, LIMITED
- 13.5.1 DAIICHI SANKYO COMPANY, LIMITED Company Information
- 13.5.2 DAIICHI SANKYO COMPANY, LIMITED Oral Nonsteroidal Anti-Inflammatory Drugs Product Offered
- 13.5.3 DAIICHI SANKYO COMPANY, LIMITED Oral Nonsteroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.5.4 DAIICHI SANKYO COMPANY, LIMITED Main Business Overview
- 13.5.5 DAIICHI SANKYO COMPANY, LIMITED Latest Developments
- 13.6 Zydus Group
- 13.6.1 Zydus Group Company Information
- 13.6.2 Zydus Group Oral Nonsteroidal Anti-Inflammatory Drugs Product Offered
- 13.6.3 Zydus Group Oral Nonsteroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.6.4 Zydus Group Main Business Overview
- 13.6.5 Zydus Group Latest Developments
- 13.7 Lupin
- 13.7.1 Lupin Company Information
- 13.7.2 Lupin Oral Nonsteroidal Anti-Inflammatory Drugs Product Offered
- 13.7.3 Lupin Oral Nonsteroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.7.4 Lupin Main Business Overview
- 13.7.5 Lupin Latest Developments
- 13.8 GSK Plc
- 13.8.1 GSK Plc Company Information
- 13.8.2 GSK Plc Oral Nonsteroidal Anti-Inflammatory Drugs Product Offered
- 13.8.3 GSK Plc Oral Nonsteroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.8.4 GSK Plc Main Business Overview
- 13.8.5 GSK Plc Latest Developments
- 13.9 Glenmark Pharmaceuticals Inc
- 13.9.1 Glenmark Pharmaceuticals Inc Company Information
- 13.9.2 Glenmark Pharmaceuticals Inc Oral Nonsteroidal Anti-Inflammatory Drugs Product Offered
- 13.9.3 Glenmark Pharmaceuticals Inc Oral Nonsteroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.9.4 Glenmark Pharmaceuticals Inc Main Business Overview
- 13.9.5 Glenmark Pharmaceuticals Inc Latest Developments
- 13.10 Amneal Pharmaceuticals
- 13.10.1 Amneal Pharmaceuticals Company Information
- 13.10.2 Amneal Pharmaceuticals Oral Nonsteroidal Anti-Inflammatory Drugs Product Offered
- 13.10.3 Amneal Pharmaceuticals Oral Nonsteroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.10.4 Amneal Pharmaceuticals Main Business Overview
- 13.10.5 Amneal Pharmaceuticals Latest Developments
- 13.11 AstraZeneca
- 13.11.1 AstraZeneca Company Information
- 13.11.2 AstraZeneca Oral Nonsteroidal Anti-Inflammatory Drugs Product Offered
- 13.11.3 AstraZeneca Oral Nonsteroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.11.4 AstraZeneca Main Business Overview
- 13.11.5 AstraZeneca Latest Developments
14 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Oral Nonsteroidal Anti-Inflammatory Drugs. Industry analysis & Market Report on Oral Nonsteroidal Anti-Inflammatory Drugs is a syndicated market report, published as Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Oral Nonsteroidal Anti-Inflammatory Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
